Liens rapides
Catégories
Fiches d'information
Les fiches d'information fournissent des informations supplémentaires sur l'industrie mondiale des protéines plasmatiques thérapeutiques.
Publications et présentations
Discover the main highlights of our industry in our latest publications.
Ressources pour les patients
Explorez les ressources de PPTA pour les patients intéressés par les thérapies aux protéines plasmatiques.
Rapports des parties prenantes
Apprenez-en plus en accédant à la collection de rapports de l'industrie.
Actualités et communiqués de presse
Restez au courant de l'actualité et des événements de l'Association.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Dec 17, 2021
A missed opportunity to acknowledge EU’s dependency on U.S. plasma
December 17, 2021 (Brussels, Belgium) — The Plasma Protein Therapeutics Association (PPTA) regrets that the publication of the European Commission report, “Study on medicine shortages,” does not include plasma, which is a biological starting material for the manufacture of lifesaving plasma-derived medicinal products (PDMPs).
All
Press releases
Dec 17, 2021
A missed opportunity to acknowledge EU’s dependency on U.S. plasma
December 17, 2021 (Brussels, Belgium) — The Plasma Protein Therapeutics Association (PPTA) regrets that the publication of the European Commission report, “Study on medicine shortages,” does not include plasma, which is a biological starting material for the manufacture of lifesaving plasma-derived medicinal products (PDMPs).
All
Press releases
Dec 1, 2021
The Source Winter 2021
Magazine of the Plasma Protein Therapeutics Industry - Winter 2021
All
The Source Magazine
https://drive.google.com/file/d/1le2D95C5zcS4gTIAPmTNSURxOSMfBFfM/view?usp=sharing
Dec 1, 2021
The Source Winter 2021
Magazine of the Plasma Protein Therapeutics Industry - Winter 2021
All
The Source Magazine
https://drive.google.com/file/d/1le2D95C5zcS4gTIAPmTNSURxOSMfBFfM/view?usp=sharing
Nov 29, 2021
Adoption of the EP report “EU Pharmaceutical Strategy”
November 24, 2021 (Brussels, Belgium) — The Plasma Protein Therapeutics Association (PPTA) congratulates MEP Montserrat (EPP, Spain) for the adoption of the report “EU Pharmaceutical Strategy” during the European Parliament’s Plenary session. The report was adopted by 527 MEPs on Wednesday 24 November.
All
Press releases
Nov 29, 2021
Adoption of the EP report “EU Pharmaceutical Strategy”
November 24, 2021 (Brussels, Belgium) — The Plasma Protein Therapeutics Association (PPTA) congratulates MEP Montserrat (EPP, Spain) for the adoption of the report “EU Pharmaceutical Strategy” during the European Parliament’s Plenary session. The report was adopted by 527 MEPs on Wednesday 24 November.
All
Press releases
Oct 4, 2021
Calling on EU Policymakers to Increase Plasma Donations
October 4, 2021 (Brussels, Belgium) — The Plasma Protein Therapeutics Association (PPTA) is marking the 9th annual International Plasma Awareness Week (IPAW), October 4-8, by increasing awareness and understanding about the importance of plasma, particularly the urgent need to increase plasma donations in the European Union, while also recognizing and thanking plasma donors who save and improve the lives of patients who rely on plasma for their therapies.
All
Press releases
Oct 4, 2021
Calling on EU Policymakers to Increase Plasma Donations
October 4, 2021 (Brussels, Belgium) — The Plasma Protein Therapeutics Association (PPTA) is marking the 9th annual International Plasma Awareness Week (IPAW), October 4-8, by increasing awareness and understanding about the importance of plasma, particularly the urgent need to increase plasma donations in the European Union, while also recognizing and thanking plasma donors who save and improve the lives of patients who rely on plasma for their therapies.
All
Press releases
Aucun résultat n'a été trouvé